Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial (2021)

First Author: Olagunju A
Attributed to:  New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04987-8

PubMed Identifier: 33397457

Publication URI: http://europepmc.org/abstract/MED/33397457

Type: Journal Article/Review

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215